Recruiting PHASE4 INTERVENTIONAL 1-arm
NCT07225101
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
Sponsor: Johnson & Johnson
Conditions
Brain Tumor Adult Hemorrhagic Stroke, Intracerebral Neurovascular Spine Traumatic Brain Injury Wound Closure
Interventions
STRATAFIX PDS and Monocryl suture
Updated 1 time since 2025 Last updated: Nov 3, 2025 Started: Nov 1, 2025 Primary completion: Jun 30, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Brain Tumor Adult and Hemorrhagic Stroke, Intracerebral and is currently actively recruiting participants. Johnson & Johnson leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Johnson & Johnson
- University of Michigan
Data source: University of Michigan
For direct contact, visit the study record on ClinicalTrials.gov .